Wall Street is asking regulators for more time to implement a rule requiring centralized Treasury clearing as banks and funds ...

Wall Street tumbled on fears the big U.S. companies that have feasted on the artificial-intelligence frenzy are under threat ...

We recently published a list of 12 Most Promising Growth Stocks According to Wall Street Analysts. In this article, we are ...

For years now, those who have worried about the equity market's overvaluation have been voices in the wilderness. As the bull market continued to power the market ever higher, these worriers were ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

Some "value sectors" may outperform this year, said Gordon. As long as the labor market and economy remain strong, that "creates solid ground for value to catch back up to growth," he said, after ...

Secondhand trades for private-markets funds handily topped $150 billion in 2024, thanks partly to strong demand from private-equity investment vehicles aimed at individual investors, secondary ...

H.C. Wainwright raised the firm’s price target on Akero Therapeutics (AKRO) to $72 from $50 and keeps a Buy rating on the shares after the ...

H.C. Wainwright reaffirmed its confidence in uniQure BV (NASDAQ:QURE), maintaining a Buy rating and significantly raising the price target to $70 from the previous $25. Currently trading at $15.67 ...